Search over 3,000 reports

    Atripla - API Insights, 2017

    Atripla - API Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0015
    DelveInsight's, Atripla - API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Atripla. The report also highlights the patent details of Atripla.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Scope:
    Evaluate the marketing status of Atripla to exploit opportunities for generic Atripla development opportunities
    Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Atripla
    API intelligence over Atripla and gaining primary intelligence over Active Ingredient manufacturers by country
    Make more informed business decisions from insightful and in-depth analysis of the Atripla's performance
    Atripla Overview
    Atripla Global Sales Assessment
    Atripla Historical Global Sales
    Atripla Forecasted Global Sales
    Product Description
    Mechanism of Action
    Pharmacodynamic Properties
    Pharmacokinetic Properties
    Product Details by country
    Patent Information
    Global API Manufacturers Assessment
    Active Pharmaceutical Ingredient (API) Manufacturers by Country
    Active Pharmaceutical Ingredient (API) Manufacturers by Region
    Appendix
    Methodology
    Consulting Services
    Disclaimer
    About DelveInsight
    Table 1: Atripla Historical Global Sales from 2009-2016 (in million USD)
    Table 2: Atripla Forecasted Global Sales from 2017-2022 (in million USD)
    Table 3: Atripla General Description
    Table 4: Product Details by country
    Table 5: Patent Information
    Table6: API Manufacturers by country
    Table 7: API Manufacturers by Region
    Figure 1: Atripla Historical Global Sales from 2009-2016 (in million USD)
    Figure 2: Atripla Forecasted Global Sales from 2017-2022 (in million USD)
    Figure 3: Atripla Patent Details
    Figure 4: Atripla API Manufacturers by Country
    Figure 5: Atripla API Manufacturers by Region
    Atripla
    Bristol-Myers Squibb & Gilead Sciences, LLC
    HIV-1 infection
    Atripla Marketed Drugs Overview
    Atripla Market Assessment
    Atripla API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Atripla US DMF
    Atripla US Drug Master Files
    Atripla Active Substance Master File/ EUDMF
    Atripla Generic players
    Atripla Patent Expiration
    Atripla Patent Exclusivity
    Atripla API Manufacturers
    Atripla Global Forecasted Sales Figure
    • Single User License
      (20% Off)
      $500.00
      $400
    • Site License
      (30% Off)
      $1,000.00
      $700
    • Global License
      (40% Off)
      $1,500.00
      $900

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap